therapeutics

Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
Maximilian Pistor, Andreas G F Hoepner, Yanan Lin, Simon Jung, Claudio L Bassetti, Andrew Chan, Anke Salmen, Robert Hoepner

Annals of the Rheumatic Diseases Jul 2021, annrheumdis-2021-220679; DOI: 10.1136/annrheumdis-2021-220679
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Atul Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, Xenofon Baraliakos, Lianne S Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S Kanik, Désirée van der Heijde

Annals of the Rheumatic Diseases Aug 2021, 80 (8) 1004-1013; DOI: 10.1136/annrheumdis-2020-219601
Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial
James Cheng-Chung Wei, Tae-Hwan Kim, Mitsumasa Kishimoto, Naoki Ogusu, Haeyoun Jeong, Shigeto Kobayashi

Annals of the Rheumatic Diseases Aug 2021, 80 (8) 1014-1021; DOI: 10.1136/annrheumdis-2020-219406
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study
Felix Eckstein, Marc C Hochberg, Hans Guehring, Flavie Moreau, Victor Ona, Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, Benjamin Daelken, Oliver Guenther, Christoph Ladel, Martin Michaelis, Philip G Conaghan

Annals of the Rheumatic Diseases Aug 2021, 80 (8) 1062-1069; DOI: 10.1136/annrheumdis-2020-219181
Patient research partner involvement in rheumatology clinical trials: analysis of journal articles 2016–2020
Huixin Wang, Sarah Stewart, Ben Darlow, Ben Horgan, Graham Hosie, Jane Clark, Nicola Dalbeth

Annals of the Rheumatic Diseases Aug 2021, 80 (8) 1095-1096; DOI: 10.1136/annrheumdis-2021-220138
Effects of RANKL inhibition on promoting healing of bone erosion in rheumatoid arthritis using HR-pQCT: a 2-year, randomised, double-blind, placebo-controlled trial
Ho So, Isaac T Cheng, Sze-Lok Lau, Evelyn Chow, Tommy Lam, Vivian W Hung, Edmund K Li, James F Griffith, Vivian W Lee, Lin Shi, Junbin Huang, Kitty Yan Kwok, Cheuk-Wan Yim, Tena K Li, Vincent Lo, Jolie Lee, Jack Jock-Wai Lee, Ling Qin, Lai-Shan Tam

Annals of the Rheumatic Diseases Aug 2021, 80 (8) 981-988; DOI: 10.1136/annrheumdis-2021-219846
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis
Kristina Elizabeth Neergaard Clark, Corrado Campochiaro, Eszter Csomor, Adam Taylor, Katherine Nevin, Nicholas Galwey, Mary A Morse, Jennifer Singh, Yee Voan Teo, Voon H Ong, Emma Derrett-Smith, Nicolas Wisniacki, Shaun M Flint, Christopher P Denton

Annals of the Rheumatic Diseases Jul 2021, annrheumdis-2021-220402; DOI: 10.1136/annrheumdis-2021-220402
Response to: ‘Correspondence on ‘Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial’’ by Cai and Peng
Anna Molto, Désirée van der Heijde, Filip E Van den Bosch, Maxime Dougados

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220913; DOI: 10.1136/annrheumdis-2021-220913
Response to: ‘Correspondence on ‘Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial’’ by Zhao and Huang
James Cheng-Chung Wei, Tae-Hwan Kim, Mitsumasa Kishimoto, Naoki Ogusu, Haeyoun Jeong, Shigeto Kobayashi

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220788; DOI: 10.1136/annrheumdis-2021-220788
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results
Josef S Smolen, Stefan Siebert, Tatiana V Korotaeva, Carlo Selmi, Paul Bergmans, Elisa Gremese, Beatriz Joven-Ibáñez, Gkikas Katsifis, Wim Noël, Michael T Nurmohamed, Pascal Richette, Petros P Sfikakis, Kurt de Vlam, Elke Theander, Laure Gossec

Annals of the Rheumatic Diseases Jun 2021, annrheumdis-2021-220263; DOI: 10.1136/annrheumdis-2021-220263

Main menu

therapeutics

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

therapeutics

Pages